Find Research outputs

Search results

• Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its effect on gametogenesis and early pregnancy

  Singh, B., Gornet, M., Sims, H., Kisanga, E., Knight, Z. & Segars, J., Nov 1 2020, In: American Journal of Reproductive Immunology. 84, 5, e13351.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Gametogenesis 100%
  • Severe Acute Respiratory Syndrome 89%
  • Coronavirus 87%
  • Pregnancy 42%
  • Publications 16%

• The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles

  Schaecher, S. R., Mackenzie, J. M. & Pekosz, A., Jan 2007, In: Journal of virology. 81, 2, p. 718-731 14 p.

  Research output: Contribution to journal › Article › peer-review

  • Severe acute respiratory syndrome coronavirus 100%
  • Severe Acute Respiratory Syndrome 74%
  • Coronavirus 72%
  • Viruses 38%
  • viruses 37%

• The value of decreasing the duration of the infectious period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection

  Lee, B. Y., Bartsch, S. M., Ferguson, M. C., Wedlock, P. T., O'Shea, K. J., Siegmund, S. S., Cox, S. N. & McKinnell, J. A., Jan 7 2021, In: PLoS computational biology. 17, 1, e1008470.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Severe acute respiratory syndrome coronavirus 100%
  • Severe Acute Respiratory Syndrome 90%
  • severe acute respiratory syndrome 88%
  • Vaccines 79%
  • Coronavirus 72%

• Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV

  Liu, Y. V., Massare, M. J., Barnard, D. L., Kort, T., Nathan, M., Wang, L. & Smith, G., Sep 2 2011, In: Vaccine. 29, 38, p. 6606-6613 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Severe acute respiratory syndrome coronavirus 100%
  • Coronavirus Spike Glycoproteins 97%
  • SARS Virus 85%
  • Severe Acute Respiratory Syndrome 74%
  • virus-like particles 74%

• Further evidence for bats as the evolutionary source of middle east respiratory syndrome coronavirus

  Anthony, S. J., Gilardi, K., Menachery, V. D., Goldstein, T., Ssebide, B., Mbabazi, R., Navarrete-Macias, I., Liang, E., Wells, H., Hicks, A., Petrosov, A., Byarugaba, D. K., Debbink, K., Dinnon, K. H., Scobey, T., Randell, S. H., Yount, B. L., Cranfield, M., Johnson, C. K., Baric, R. S. & 2 others, Lipkin, W. I. & Mazet, J. A. K., Mar 1 2017, In: mBio. 8, 2, e00373-17.

  Research output: Contribution to journal › Article › peer-review

  • Middle East Respiratory Syndrome Coronavirus 100%
  • Zoonoses 31%
  • Viruses 19%
  • Uganda 17%
  • Genetic Recombination 14%

• Estimating the severity and subclinical burden of middle east respiratory syndrome coronavirus infection in the Kingdom of Saudi Arabia

  Lessler, J., Salje, H., Van Kerkhove, M. D., Ferguson, N. M., Cauchemez, S., Rodriquez-Barraquer, I., Hakeem, R., Jombart, T., Aguas, R., Al-Barrak, A. & Cummings, D. A. T., Apr 1 2016, In: American journal of epidemiology. 183, 7, p. 657-663 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Middle East Respiratory Syndrome Coronavirus 100%
  • Saudi Arabia 75%
  • Confidence Intervals 33%
  • Statistical Models 12%

• A single tyrosine in the severe acute respiratory syndrome coronavirus membrane protein cytoplasmic tail is important for efficient interaction with spike protein

  McBride, C. E. & Machamer, C. E., Feb 2010, In: Journal of virology. 84, 4, p. 1891-1901 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Severe acute respiratory syndrome coronavirus 100%
  • Severe Acute Respiratory Syndrome 74%
  • Coronavirus 72%
  • Tyrosine 53%
  • membrane proteins 53%

• SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801

  Wahl, A., Gralinski, L. E., Johnson, C. E., Yao, W., Kovarova, M., Dinnon, K. H., Liu, H., Madden, V. J., Krzystek, H. M., De, C., White, K. K., Gully, K., Schäfer, A., Zaman, T., Leist, S. R., Grant, P. O., Bluemling, G. R., Kolykhalov, A. A., Natchus, M. G., Askin, F. B. & 6 others, Painter, G., Browne, E. P., Jones, C. D., Pickles, R. J., Baric, R. S. & Garcia, J. V., Mar 18 2021, In: Nature. 591, 7850, p. 451-457 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Severe Acute Respiratory Syndrome 90%
  • Coronavirus 76%
  • Lung 28%
  • Middle East Respiratory Syndrome Coronavirus 13%
  • Infections 12%

• Preventing healthcare-associated transmission of the Middle East Respiratory Syndrome (MERS): Our Achilles heel

  Balkhy, H. H., Perl, T. M. & Arabi, Y. M., May 1 2016, In: Journal of Infection and Public Health. 9, 3, p. 208-212 5 p.

  Research output: Contribution to journal › Editorial › peer-review

  • Middle East 63%
  • Healthcare 53%
  • Delivery of Health Care 42%
  • Disease Outbreaks 41%
  • Coronaviridae 41%

• Community-Onset Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Young Infants: A Systematic Review

  Mark, E. G., Golden, W. C., Gilmore, M. M., Sick-Samuels, A., Curless, M. S., Nogee, L. M., Milstone, A. M. & Johnson, J., Jan 2021, In: Journal of Pediatrics. 228, p. 94-100.e3

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Severe Acute Respiratory Syndrome 90%
  • Systematic Reviews 51%
  • Coronavirus 43%
  • Fever 17%
  • Lymphopenia 14%

• COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva

  Pisanic, N., Randad, P. R., Kruczynski, K., Manabe, Y. C., Thomas, D. L., Pekosz, A., Klein, S. L., Betenbaugh, M. J., Clarke, W. A., Laeyendecker, O., Caturegli, P. P., Benjamin Larman, H., Detrick, B., Fairley, J. K., Sherman, A. C., Rouphael, N., Edupuganti, S., Granger, D. A., Granger, S. W., Collins, M. H. & 1 others, Heaney, C. D., Jan 2021, In: Journal of clinical microbiology. 59, 1, e02204-20.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Severe Acute Respiratory Syndrome 100%
  • Coronavirus 97%
  • Serology 82%
  • Antibody Formation 69%
  • Immunoglobulin G 36%

• Genetic Spectrum and Distinct Evolution Patterns of SARS-CoV-2

  Liu, S., Shen, J., Fang, S., Li, K., Liu, J., Yang, L., Hu, C. D. & Wan, J., Sep 25 2020, In: Frontiers in Microbiology. 11, 593548.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Nucleotides 54%
  • Coronavirus 42%
  • Genome 34%
  • Mutation 18%

• Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors

  Sisk, J. M., Frieman, M. B. & Machamer, C. E., May 2018, In: Journal of General Virology. 99, 5, p. 619-630 12 p., 001047.

  Research output: Contribution to journal › Article › peer-review

  • Infectious bronchitis virus 100%
  • Coronavirus 81%
  • Middle East Respiratory Syndrome Coronavirus 58%
  • Phosphotransferases 49%
  • Severe Acute Respiratory Syndrome 33%

• CD8⁺ T cells and macrophages regulate pathogenesis in a mouse model of Middle East respiratory syndrome

  Coleman, C. M., Sisk, J. M., Halasz, G., Zhong, J., Beck, S. E., Matthews, K. L., Venkataraman, T., Rajagopalan, S., Kyratsous, C. A. & Frieman, M. B., 2017, In: Journal of virology. 91, 1, e01825-16.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Middle East respiratory syndrome coronavirus 100%
  • Middle East Respiratory Syndrome Coronavirus 86%
  • Middle East 64%
  • T-lymphocytes 52%
  • pathogenesis 52%

• The cytoplasmic tails of infectious bronchitis virus E and M proteins mediate their interaction

  Corse, E. & Machamer, C. E., Jul 20 2003, In: Virology. 312, 1, p. 25-34 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Infectious bronchitis virus 100%
  • Virion 49%
  • Coronavirus M protein 25%
  • Proteins 23%
  • Virus Release 17%

• Palmitoylation of SARS-CoV S protein is necessary for partitioning into detergent-resistant membranes and cell-cell fusion but not interaction with M protein

  McBride, C. E. & Machamer, C. E., Sep 2010, In: Virology. 405, 1, p. 139-148 10 p.

  Research output: Contribution to journal › Article › peer-review

  • S protein, severe acute respiratory syndrome coronavirus 100%
  • Lipoylation 74%
  • Coronavirus 65%
  • Cell Fusion 61%
  • Detergents 54%

• Durable SARS-CoV-2 B cell immunity after mild or severe disease

  Ogega, C. O., Skinner, N. E., Blair, P. W., Park, H. S., Littlefield, K., Ganesan, A., Dhakal, S., Ladiwala, P., Antar, A. A. R., Ray, S. C., Betenbaugh, M. J., Pekosz, A., Klein, S. L., Manabe, Y. C., Cox, A. L. & Bailey, J. R., Apr 1 2021, In: Journal of Clinical Investigation. 131, 7, e145516.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Immunity 55%
  • B-Lymphocytes 52%
  • Protein Binding 48%
  • Coronavirus 36%

• Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice

  Coleman, C. M., Liu, Y. V., Mu, H., Taylor, J. K., Massare, M., Flyer, D. C., Glenn, G. M., Smith, G. E. & Frieman, M. B., May 30 2014, In: Vaccine. 32, 26, p. 3169-3174 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Coronavirus Spike Glycoproteins 100%
  • Coronavirinae 78%
  • Coronavirus 74%
  • neutralizing antibodies 68%
  • Neutralizing Antibodies 59%

• Point-of-use rapid detection of sars-cov-2: Nanotechnology-enabled solutions for the covid-19 pandemic

  Rabiee, N., Bagherzadeh, M., Ghasemi, A., Zare, H., Ahmadi, S., Fatahi, Y., Dinarvand, R., Rabiee, M., Ramakrishna, S., Shokouhimehr, M. & Varma, R. S., Jul 2 2020, In: International journal of molecular sciences. 21, 14, p. 1-23 23 p., 5126.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Nanotechnology 100%
  • Viruses 98%
  • nanotechnology 94%
  • Pandemics 89%
  • viruses 75%

• Risk Factors Associated with SARS-CoV-2 Seropositivity among US Health Care Personnel

  Jacob, J. T., Baker, J. M., Fridkin, S. K., Lopman, B. A., Steinberg, J. P., Christenson, R. H., King, B., Leekha, S., O'Hara, L. M., Rock, P., Schrank, G. M., Hayden, M. K., Hota, B., Lin, M. Y., Stein, B. D., Caturegli, P., Milstone, A. M., Rock, C., Voskertchian, A., Reddy, S. C. & 1 others, Harris, A. D., Mar 10 2021, In: JAMA Network Open. 4, 3, e211283.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Severe Acute Respiratory Syndrome 100%
  • Coronavirus 97%
  • Health Personnel 67%
  • Delivery of Health Care 47%
  • Workplace 32%

• Estimating the burden of SARS-CoV-2 in France

  Salje, H., Kiem, C. T., Lefrancq, N., Courtejoie, N., Bosetti, P., Paireau, J., Andronico, A., Hozé, N., Richet, J., Dubost, C. L., Le Strat, Y., Lessler, J., Levy-Bruhl, D., Fontanet, A., Opatowski, L., Boelle, P. Y. & Cauchemez, S., Jul 10 2020, In: Science. 369, 6500, p. 208-211 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Severe Acute Respiratory Syndrome 100%
  • Coronavirus 97%
  • France 72%
  • Immunity 42%
  • Population 30%

• An immunosuppressed Syrian golden hamster model for SARS-CoV infection

  Schaecher, S. R., Stabenow, J., Oberle, C., Schriewer, J., Buller, R. M., Sagartz, J. E. & Pekosz, A., Oct 25 2008, In: Virology. 380, 2, p. 312-321 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Severe Acute Respiratory Syndrome 90%
  • Coronavirus 87%
  • Mesocricetus 84%
  • Cricetinae 53%
  • Mortality 26%

• A narrative review of coronavirus disease 2019 (COVID-19): clinical, epidemiological characteristics, and systemic manifestations

  Krishnan, A., Hamilton, J. P., Alqahtani, S. A. & A.Woreta, T., Jun 2021, In: Internal and Emergency Medicine. 16, 4, p. 815-830 16 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Coronavirus 100%
  • Severe Acute Respiratory Syndrome 34%
  • Respiratory System 25%
  • Betacoronavirus 23%
  • angiotensin converting enzyme 2 19%

• Lack of transmission among close contacts of patient with case of middle east respiratory syndrome imported into the United States, 2014

  Breakwell, L., Pringle, K., Chea, N., Allen, D., Allen, S., Richards, S., Pantones, P., Sandoval, M., Liu, L., Vernon, M., Conover, C., Chugh, R., Demaria, A., Burns, R., Smole, S., Gerber, S. I., Cohen, N. J., Kuhar, D., Haynes, L. M., Schneider, E. & 5 others, Kumar, A., Kapoor, M., Madrigal, M., Swerdlow, D. L. & Feikin, D. R., 2015, In: Emerging infectious diseases. 21, 7, p. 1128-1134 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Middle East Respiratory Syndrome Coronavirus 100%
  • Health Personnel 57%
  • Geographic Information Systems 44%
  • Delivery of Health Care 40%
  • Saudi Arabia 18%

• Epidemiological and clinical characteristics of discharged patients infected with SARS-CoV-2 on the Qinghai Plateau

  Xi, A., Zhuo, M., Dai, J., Ding, Y., Ma, X., Ma, X., Wang, X., Shi, L., Bai, H., Zheng, H., Nuermberger, E. & Xu, J., Nov 1 2020, In: Journal of Medical Virology. 92, 11, p. 2528-2535 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Severe Acute Respiratory Syndrome 100%
  • Coronavirus 97%
  • Comorbidity 12%
  • Tibet 11%
  • Noninvasive Ventilation 9%